Larry Ramer

Larry Ramer

Larry Ramer has more than 15 years of experience in business journalism. He has worked for Globes, Israel’s most widely read business newspaper, as well as The Jerusalem Post and theflyonthewall.

Mr. Ramer’s expansive knowledge of politics enables him to provide valuable insights into how politics can affect stocks. He also focuses on contrary investing and specializes in the renewable energy and consumer discretionary sectors.

Among his highly successful, contrarian picks have been Super Micro Computer, Intel, and MGM Resorts.

You can reach him on StockTwits at @larryramer and learn more about his stock-picking record at his TipRanks profile.

Recent Articles

The Meme Stock Trend Is Dying, So Get Out of Clover Health Now

As Clover Health faces government probes, multiple signs suggest that the company is not a tech powerhouse. Meanwhile, Wall Street has soured on CLOV stock.

American Superconductor Is a Great Play on Multiple Trends

Representing a great way to profit from multiple, strong trends, AMSC stock is tremendously undervalued and is quite attractive.

JinkoSolar Stock: Ridiculously Undervalued and Benefiting From Short Squeeze

JKS stock is extremely undervalued, as the Street is greatly underestimating the size of the company's future top and bottom lines.

Be Cautious on IBM Stock Until After Whitehurst’s Resignation Shakes Out

After IBM President Jim Whitehurst resigned, investors should not buy IBM stock. A wait-and-see approach is preferable.

4 Highly Promising Meme Stocks to Buy Now

Not all meme stocks are overvalued. These four meme stocks are good buys, as they're poised to deliver big profits for investors.

New Developments Have Made Vaxart Stock So Much More Attractive

Vaxart recently made a licensing deal, and two research firms issued upbeat assessments of the company, making me more upbeat on VXRT stock.

Advertising’s Most Important Rule Explains Why Skillz Stock Is a Sell

With its small audience and limited growth potential, Skillz will not be very attractive to advertisers. Meanwhile, the valuation of SKLZ stock is huge.

Strong, Positive Catalysts Make GE Stock a Buy on Weakness

Among the catalysts likely to boost GE stock are the rebound of the aviation sector and upcoming spending initiatives from Congress.

Stay Away From Low-Growth Organon

Organon's low growth, lack of strong catalysts and likely average future dividend combine to make OGN stock unattractive.

Xpeng’s Positive Catalysts Should Lift XPEV Stock Much Higher

With Xpeng's EV sales growing tremendously and the automaker poised to benefit from Tesla's difficulties in China, XPEV stock is a buy.